Loading...
AstraZeneca PLC
AZN•NASDAQ
Healthcare
Drug Manufacturers - General
$74.41
$-0.59(-0.79%)
AstraZeneca PLC (AZN) AI-Powered Stock Analysis
See how AstraZeneca PLC scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerAstraZeneca PLC (AZN) Stock Overall Grade
AstraZeneca PLC’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
A
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to AstraZeneca PLC's overall stock rating.
Forecast
A+Score
100/100Financial Growth
A+Score
100/100Fundamental Growth
A+Score
90/100Key Ratios
BScore
68/100Sector Comparison
B+Score
75/100Industry Comparison
A+Score
90/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
B+Score
75/100Component Analysis Explained
Understand the key factors behind each AstraZeneca PLC stock grade, including financials, comparisons, and forecasts.